BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PTEN
,
Response to oxidative stress
,
HIV infection
,
Stem cell
,
Hematopoietic cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
angiotensin receptor- binding
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Brain AT1 angiotensin receptor subtype binding: importance of peptidase inhibition for identificatio…
The physiology and pathophysiology of a novel angiotensin receptor-binding protein ATRAP/Agtrap.
Angiotensin Receptor-Binding Protein ATRAP/Agtrap Inhibits Metabolic Dysfunction With Visceral Obesi…
Changes in angiotensin type 1 receptor binding and angiotensin-induced pressor responses in the rost…
Chronic ACE inhibitor treatment increases angiotensin type 1 receptor binding in vivo in the dog kid…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in P…
Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease
Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor T…
Reducing Acute Kidney Injury Occurence by Administering Angiotensin II
Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respi…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ